Literature DB >> 22129976

Success of immunomodulators in MS shifts discovery focus to neuroprotection.

Asher Mullard.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22129976     DOI: 10.1038/nrd3610

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Trial watch: integrin antagonist shows promise in MS.

Authors:  Sarah Crunkhorn
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Oligodendroglial maturation is dependent on intracellular protein shuttling.

Authors:  Peter Göttle; Jennifer K Sabo; André Heinen; Gene Venables; Klintsy Torres; Nevena Tzekova; Carlos M Parras; David Kremer; Hans-Peter Hartung; Holly S Cate; Patrick Küry
Journal:  J Neurosci       Date:  2015-01-21       Impact factor: 6.167

3.  Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation.

Authors:  Janusz Joachim Jadasz; David Kremer; Peter Göttle; Nevena Tzekova; Julia Domke; Francisco J Rivera; James Adjaye; Hans-Peter Hartung; Ludwig Aigner; Patrick Küry
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.